1031 related articles for article (PubMed ID: 16818854)
1. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
2. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
Duggan C; Marriott K; Edwards R; Cuzick J
J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
4. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
Decensi A; Maisonneuve P; Rotmensz N; Bettega D; Costa A; Sacchini V; Salvioni A; Travaglini R; Oliviero P; D'Aiuto G; Gulisano M; Gucciardo G; del Turco MR; Pizzichetta MA; Conforti S; Bonanni B; Boyle P; Veronesi U;
Circulation; 2005 Feb; 111(5):650-6. PubMed ID: 15699284
[TBL] [Abstract][Full Text] [Related]
5. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
Garber JE; Halabi S; Tolaney SM; Kaplan E; Archer L; Atkins JN; Edge S; Shapiro CL; Dressler L; Paskett ED; Kimmick G; Orcutt J; Scalzo A; Winer E; Levine E; Shahab N; Berliner N;
J Natl Cancer Inst; 2010 Jul; 102(13):942-9. PubMed ID: 20554945
[TBL] [Abstract][Full Text] [Related]
7. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
[TBL] [Abstract][Full Text] [Related]
8. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
10. Stroke risk and tamoxifen therapy for breast cancer.
Geiger AM; Fischberg GM; Chen W; Bernstein L
J Natl Cancer Inst; 2004 Oct; 96(20):1528-36. PubMed ID: 15494603
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
12. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.
Pihusch R; Danzl G; Scholz M; Harich D; Pihusch M; Lohse P; Hiller E
Cancer; 2002 Jun; 94(12):3120-6. PubMed ID: 12115343
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
15. [The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].
Schramm W; Heinemann LA; Spannagl M; Dick A; Assmann A
Dtsch Med Wochenschr; 2000 Jan; 125(1-2):2-6. PubMed ID: 10650817
[TBL] [Abstract][Full Text] [Related]
16. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
Weitz IC; Israel VK; Liebman HA
Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
Yilmazer M; Kurtay G; Sonmezer M; Akar N
Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
[TBL] [Abstract][Full Text] [Related]
19. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
Ganz PA; Land SR
Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
[TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism.
Bonduel M; Hepner M; Sciuccati G; Pieroni G; Feliú-Torres A; Mardaraz C; Frontroth JP
Thromb Haemost; 2002 Jun; 87(6):972-7. PubMed ID: 12083504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
